Two Seas Capital LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $297 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $112M, Arbutus Biopharma Corp with a value of $32.3M, Vistra Corp. with a value of $30M, Meta Platforms, Inc. with a value of $20.6M, and Immunovant, Inc. with a value of $18.6M.

Examining the 13F form we can see an increase of $47.2M in the current position value, from $250M to 297M.

Two Seas Capital LP is based out at Rye, NY

Below you can find more details about Two Seas Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $297 Million
Healthcare: $221 Million
Utilities: $36.5 Million
Communication Services: $27.2 Million
Technology: $6.5 Million
Financial Services: $5.79 Million
Industrials: $83,000

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $297 Million
  • Prior Value $250 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Two Seas Capital LP Portfolio

Follow Two Seas Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.